{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:46:29Z","timestamp":1793213189814,"version":"4.5.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00198-021-06233-6","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T14:03:02Z","timestamp":1637935382000},"page":"937-941","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Multiple myeloma screening within a fracture liaison service (FLS)"],"prefix":"10.1007","volume":"33","author":[{"given":"G.","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Milan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Mohsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Connacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K.","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"6233_CR1","unstructured":"Royal Osteoporosis Society. Effective secondary prevention of fragility fractures\u202f: clinical standards for fracture liaison services. R. Osteoporos. Soc. (2019)."},{"key":"6233_CR2","unstructured":"Falls and Fragility Fractures."},{"key":"6233_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s001980200084","volume":"13","author":"TP Van Staa","year":"2002","unstructured":"Van Staa TP, Leufkens HGM, Cooper C (2002) Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporos Int 13:624\u2013629","journal-title":"Osteoporos Int"},{"key":"6233_CR4","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1182\/blood.V90.9.3743","volume":"90","author":"M Pecherstorfer","year":"1997","unstructured":"Pecherstorfer M et al (1997) Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen. Blood 90:3743\u20133750","journal-title":"Blood"},{"key":"6233_CR5","first-page":"1142","volume":"58","author":"G Nador","year":"2019","unstructured":"Nador G et al (2019) Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures. Rheumatol (United Kingdom) 58:1142\u20131153","journal-title":"Rheumatol (United Kingdom)"},{"key":"6233_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00774-017-0817-8","volume":"36","author":"N Veronese","year":"2018","unstructured":"Veronese N et al (2018) Monoclonal gammopathy of undetermined significance and bone health outcomes: a systematic review and exploratory meta-analysis. J Bone Miner Metab 36:128\u2013132","journal-title":"J Bone Miner Metab"},{"key":"6233_CR7","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/bmj.38376.401701.8F","volume":"330","author":"B Abrahamsen","year":"2005","unstructured":"Abrahamsen B, Andersen I, Christensen SS, Madsen JS, Brixen K (2005) Utility of testing for monoclonal bands in serum of patients with suspected osteoporosis: retrospective, cross sectional study. Br Med J 330:818\u2013820","journal-title":"Br Med J"},{"key":"6233_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2052-1839-13-9","volume":"13","author":"DA Howell","year":"2013","unstructured":"Howell DA et al (2013) Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological malignancy Research Network. BMC Hematol 13:9","journal-title":"BMC Hematol"},{"key":"6233_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S1470-2045(12)70041-4","volume":"13","author":"G Lyratzopoulos","year":"2012","unstructured":"Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA (2012) Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol 13:353\u2013365","journal-title":"Lancet Oncol"},{"key":"6233_CR10","doi-asserted-by":"crossref","unstructured":"R\u00f6gnvaldsson, S. et al. Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies. Blood Cancer J. 11, (2021).","DOI":"10.1038\/s41408-021-00480-w"},{"key":"6233_CR11","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle RA et al (2010) Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 24:1121\u20131127","journal-title":"Leukemia"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06233-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-021-06233-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06233-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T03:06:21Z","timestamp":1647572781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-021-06233-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["6233"],"URL":"https:\/\/doi.org\/10.1007\/s00198-021-06233-6","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was registered as a service evaluation project and received clinical governance approval by Oxford University Hospitals (OUH) NHS Foundation Trust.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"N\/A","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}